News

06/12/2015

Nancy Chiaravalloti, PhD, the director of the Neuropsychology and Neuroscience Laboratory and Traumatic Brain Injury Laboratory at Kessler Foundation Research Center, discussed various strategies for cognitive rehabilitation. Dr. Chiaravalloti noted that 65% of MS patients suffer from cognitive impairment—many reporting difficulties with memory and processing speed. A large part of her presentation focused on a new study for which the IMSMP is a participating site: Memory and Multiple... more

05/27/2015

Dr. Armistead Williams discussed the most recently FDA-approved MS medication, Alemtuzumab, at today’s grand rounds. His discussion of this medication included the following points: Two courses of this potent drug can give people with RRMS 5 years of benefit. The risks include infections and developing a new autoimmune disease, 1 in 3 will get autoimmune thyroid disease and 3% will develop a more serious disease. We have not proven yet that this medication will alter the long term risk of... more

05/22/2015

The IMSMP will be closed at 1:30pm today and remain closed through Monday, May 25th. A neurologist will be available for any emergencies by calling (212) 265-8070. We wish everyone a safe and healthy holiday weekend!

05/15/2015

Summer is almost here! Sunlight is the best natural source of vitamin D, a nutrient that helps regulate the immune response and may be especially beneficial for people with MS. 

What’s the best way to get a natural dose of this necessary nutrient? 

It’s very difficult to get enough vitamin D from sunlight most months of the year unless you live close to the equator. Now that the sunlight is finally getting stronger in the northern latitudes, try to spend some time outside... more

05/13/2015

Margaret Zellner, PhD, from The Neuropsychoanalysis Foundation spoke at Tisch MS Research Center’s Grand Rounds today. Dr. Zellner discussed the anatomical and physiological basis for various neuropsychological phenomena, including emotion and cognition. The discussion also involved how disorders like multiple sclerosis can disrupt these pathways and networks to produce neuropsychological symptoms. 

05/04/2015

The IMSMP welcomed Cristina Dorazio, Ph.D., a psychologist in private practice in NYC, to present a Grand Rounds presentation on Wednesday, April 29, 2015 on “The Power of Mindfulness: Implications for Your Practice”.  Dr. Dorazio explained the fundamentals of mindfulness, the practice of focusing one’s attention purposefully in the moment and paying attention to the breath as a way to calm anxiety.  She shared scientific studies that have shown a correlation between the use of mindfulness... more

04/23/2015

Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial for Patients with Multiple Sclerosis

New York, NY - April 23, 2015 - Tisch MS Research Center of New York (Tisch MSRCNY) today announced encouraging preliminary results from its FDA-approved Phase I trial using autologous neural stem cells in the treatment of multiple sclerosis (MS). MS is a chronic autoimmune disease of the central nervous system where the myelin sheath is attacked and... more

04/09/2015

Check out these 2 videos with expert advice by Dr. James W. Stark on MS symptoms and relapses. http://www.everydayhealth.com/health-report/multiple-sclerosis-symptoms/ms-expert-stark-schaefer-videos.aspx 

Pages

IMSMP

Because you deserve only the best in MS healthcare. Experience the difference.

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.